The new space comes as 1776 shifts in its D.C.-area footprint.
A new analysis finds that more physicians are gaining telemedicine skills, an industry that’s expected to grow to over $130 billion by 2025. Here’s more from the report:
After bouncing back last year both in dollars raised and number of deals, the initial public offering (IPO) market was expected to at least approach that success this year.
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? Schedule your feedback session with BHI EIRs on one of the following dates:
- 7/24/19 (All slots filled)
- 9/4/19
- 10/9/19
- 11/20/19
- 1/22/20
- 2/26/20
- 3/25/20
- 4/22/20
- 5/27/20
(45 minute blocks of time beginning at 9:00 in the morning. If the morning slots are filled, more time will be allotted beginning at 1 p.m.)
These take place at BHI headquarters in Rockville or by videoconference via Zoom.
Pre-registration and forwarding of a power point deck one week before the session is required. Sign up here (“EIR resource” at BHI HQ, Rockville). For questions, more information, or to be added to the wait list, please contact BHI.
How did Virginia manage to snag the biggest economic development prize in recent memory?
Amazon says its abrupt decision in February to pull out of a deal to build part of its giant second headquarters in Long Island City, Queens, was not about politics, despite speculation to the contrary. But when opposition in New York grew, Chairman Jeff Bezos and his team decided it only made sense to focus their efforts on the other victor in the HQ2 sweepstakes: Northern Virginia.
Drones have made the news once again. This time, to aid in swift and reliable delivery of life-saving temperature-controlled medications required in emergency situations. A collaboration between Direct Relief, Merck (MSD outside the U.S. and Canada), Softbox, AT&T and Volans-i is pushing the boundaries and capabilities of UAVs- also known as drones, and confirmed a successful fourth pilot proof-of-concept mission was conducted in the Bahamas last week.
A leading genomics company with international reach is opening its first commercial location on the East Coast at Baltimore’s University Maryland BioPark.
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the appointment of Andrew Eisen, M.D., Ph.D. as VP, Clinical Development. Dr. Eisen is a translational medicine and clinical development specialist with over 20 years of experience in the biotech and pharma sectors.
For Jim Allison, cancer has always been at the back of his mind. He’d lost many family members to the disease, including his mother when he was young, and is himself a cancer survivor.
